| Literature DB >> 30116505 |
Mohammad Esmaeil Motlagh1,2, Mostafa Qorbani3, Amir-Masood Rafiemanzelat4, Majzoubeh Taheri5, Tahereh Aminaee5, Gita Shafiee6, Zeinab Ahadi6, Mahshid Hajiali7, Kimia Ghaderi4, Ali Safaei4, Azam Goodarzi8, Hasan Ziaodini9, Ramin Heshmat6, Roya Kelishadi10.
Abstract
Introduction: This study presents the prevalence of cardiometabolic risk factors in a nationally representative sample of Iranian children and adolescents.Entities:
Keywords: Adolescents; Cardiometabolic; Children; Prevalence
Year: 2018 PMID: 30116505 PMCID: PMC6088761 DOI: 10.15171/jcvtr.2018.12
Source DB: PubMed Journal: J Cardiovasc Thorac Res ISSN: 2008-5117
Characteristics of participants by age, gender, and living area: the CASPIAN-V Study
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
| |||||||||||||
| Gender | Boy | 42.36±18.23 | 148.15±18.77 | 67.65±12.87 | 99.55±13.43 | 64.08±10.70 | 92.06±12.91 | 87.15±45.52 | 152.96±28.06 | 46.21±10.17 | 89.31±22.90 | 8.49±5.11 | 18.48±4.96 |
| Girl | 40.41±15.42 | 144.93±15.93 | 65.76±11.33 | 98.77±12.72 | 63.57±10.14 | 91.20±11.14 | 89.02±44.78 | 154.83±26.67 | 46.16±9.75 | 90.86±22.26 | 8.16±8.73 | 18.53±4.43 | |
|
| <0.001 | <0.001 | <0.001 | <0.001 | 0.004 | 0.027 | 0.021 | 0.035 | 0.86 | 0.03 | 0.13 | 0.56 | |
| Residence area | Urban | 43.66±17.73 | 148.62±17.74 | 68.27±12.27 | 100.15±13.05 | 64.28±10.45 | 91.76±12.56 | 88.47±45.54 | 153.77±27.64 | 46.25±10.19 | 89.83±22.81 | 8.41±7.90 | 18.98±4.83 |
| Rural | 35.75±13.96 | 141.42±15.75 | 62.85±11.02 | 96.70±12.86 | 62.72±10.29 | 91.36±10.84 | 86.92±44.21 | 154.04±26.84 | 46.02±9.38 | 90.63±22.06 | 8.12±4.16 | 17.32±4.16 | |
|
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.35 | 0.33 | 0.78 | 0.51 | 0.32 | 0.13 | <0.001 | |
| Age (y) | 7-10 | 27.69±8.80 | 130.05±10.15 | 59.55±9.05 | 93.99±12.72 | 60.82±10.35 | 91.67±14.00 | 87.12±45.64 | 154.72±29.21 | 47.08±10.60 | 90.21±24.12 | 8.43±6.76 | 16.18±4.03 |
| 11-14 | 42.05±13.11 | 148.85±11.79 | 67.47±11.18 | 99.43±12.33 | 63.94±9.97 | 91.77±11.33 | 87.76±44.37 | 154.07±26.30 | 46.04±9.75 | 90.47±21.69 | 8.26±4.79 | 18.66±4.41 | |
| 15-18 | 57.68±15.43 | 164.01±12.27 | 74.66±11.70 | 105.25±11.89 | 67.44±10.01 | 91.44±11.02 | 89.50±45.94 | 152.53±27.10 | 45.43±9.54 | 89.20±22.31 | 8.34±9.88 | 21.21±4.42 | |
|
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.79 | 0.44 | 0.16 | <0.001 | 0.34 | 0.83 | <0.001 | |
| Total | 41.39±17.11 | 146.56±17.50 | 66.72±12.17 | 99.17±13.09 | 63.83±10.43 | 91.65±12.11 | 88.04±45.18 | 153.85±27.42 | 46.19±9.97 | 90.05±22.60 | 8.33±7.07 | 18.51±4.71 | |
Abbreviations: WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TG, triglyceride; ALT, alanine transaminase; BMI, body mass index; HDL, High-density lipoprotein; LDL, Low-density lipoprotein.
*According to independent sample t-test
**According to ANOVA test
P< 0.05 is significant.
Prevalence of cardiometabolic risk factors by age, gender, and living area: the CASPIAN-V study
|
|
|
|
| |||||||||
|
|
|
|
|
|
|
|
|
|
| |||
| Weight status | Underweight | 2279 (16.1) | 1249 (17.4) | 1030 (14.8) | <0.001 | 1443 (14.3) | 810(20) | <0.001 | 900(18.8) | 861(15.5) | 492(12.9) | <0.001 |
| Normal | 8914 (63) | 4403 (61.4) | 4511 (64.7) | 7675 (76) | 3030 (74.9) | 3455(72.1) | 4192(75.6) | 3058(80.3) | ||||
| Overweight | 1330 (9.4) | 621 (8.7) | 709 (10.2) | 266 (2.6) | 53 (1.3) | 131(2.7) | 119(2.1) | 69(1.8) | ||||
| Obese | 1615 (11.4) | 896 (12.5) | 719 (10.3) | 711 (7) | 153 (3.8) | 305(6.4) | 372(6.7) | 187(4.9) | ||||
| Abdominal obesity | 2972 (21.1) | 1550 (21.6) | 1422 (20.5) | 0.08 | 2335 (23.2) | 637 (15.8) | <0.001 | 974(20.4) | 1156(20.9) | 842(22.2) | 0.11 | |
| High TG | 1065 (27.7) | 541(26.9) | 524 (28.6) | 0.22 | 782 (28.2) | 283 (26.5) | 0.30 | 299(26.1) | 457(27.6) | 309(29.7) | 0.17 | |
| High LDL | 674 (17.5) | 341(16.9) | 333 (18.2) | 0.31 | 489 (17.6) | 185 (17.3) | 0.83 | 208(18.1) | 282(17) | 184(17.7) | 0.74 | |
| High TC | 189 (4.9) | 100 (5) | 89 (4.9) | 0.88 | 140(5) | 49 (4.6) | 0.56 | 72(6.3) | 74(4.5) | 43(4.1) | 0.04 | |
| Low HDL | 1134 (29.5) | 658 (32.7) | 476 (26) | <0.001 | 849 (30.6) | 285 (26.7) | 0.02 | 275(24) | 428(25.9) | 431(41.4) | <0.001 | |
| High SBP | 438 (3.1) | 210 (3) | 228 (3.3) | 0.25 | 330 (3.3) | 108 (2.7) | 0.07 | 229(4.8) | 158(2.9) | 51(1.4) | <0.001 | |
| High DBP | 1450 (10.4) | 746 (10.5) | 704 (10.2) | 0.51 | 1053 (10.5) | 397 (10) | 0.32 | 427(9) | 729(13.2) | 294(7.8) | <0.001 | |
| High blood pressure | 1604 (11.5) | 815 (11.5) | 789 (11.4) | 0.87 | 1169 (11.7) | 435 (10.9) | 0.19 | 515(10.9) | 775(14.1) | 314(8.3) | <0.001 | |
| High FBG | 161 (4.2) | 96 (4.8) | 65 (3.5) | 0.06 | 116 (4.2) | 45 (4.2) | 0.96 | 47 (4.1) | 71 (4.3) | 43 (4.1) | 0.96 | |
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TG, triglyceride; HDL, High-density lipoprotein; LDL, Low-density lipoprotein; TC, total cholesterol.
*According χ2 test.